A PoP nano-composite structure includes a first nano-particle containing a drug therein, and second nano-particles that surround a surface of the first nano-particle and are coated by a protein alpha-synuclein. Combination of the nano-particles and release of the drug can be controlled by the protein alpha-synuclein.